BRCA1-related cancers

GPTKB entity

Statements (49)
Predicate Object
gptkbp:instance_of gptkb:Oncology
gptkbp:associated_with gptkb:BRCA1_gene
gptkbp:clinical_trial checkpoint inhibitors
PARP inhibitors
gptkbp:community_health increased awareness needed
genetic testing accessibility
disparities in healthcare access
need for research funding
importance of family history
gptkbp:demographics gptkb:Female
higher incidence in Ashkenazi Jews
gptkbp:diagnosis CT scan
ultrasound
biopsy
genetic counseling
varies by stage
early detection improves outcomes
higher risk of recurrence
potential for targeted treatment options
gptkbp:genetic_studies BRCA1 mutation testing
https://www.w3.org/2000/01/rdf-schema#label BRCA1-related cancers
gptkbp:includes gptkb:Oncology
ovarian cancer
gptkbp:is_involved_in Facing Our Risk of Cancer Empowered (FORCE)
BRCA1 Support Group
gptkbp:lifespan up to 44% for ovarian cancer
up to 72% for breast cancer
gptkbp:prevention prophylactic mastectomy
salpingo-oophorectomy
gptkbp:public_awareness gptkb:Breast_Cancer_Awareness_Month
gptkb:Ovarian_Cancer_Awareness_Month
gptkbp:research_focus gptkb:immunotherapy
targeted therapies
gptkbp:risk_factor gptkb:Genetics
family history
gptkbp:screenings gptkb:MRI
mammogram
gptkbp:symptoms fatigue
nausea
weight loss
changes in bowel habits
abnormal vaginal bleeding
lump in breast
pain in the pelvic area
gptkbp:treatment gptkb:surgery
radiation therapy
chemotherapy
gptkbp:bfsParent gptkb:BARD1_protein
gptkbp:bfsLayer 8